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Abstract 
 
 
 
Depression in early psychosis is linked to poor outcome, relapse and risk of suicide, 
yet remains poorly understood. This article aims to examine the development of 
depression in acute and post psychotic phases of first episode psychosis (FEP), and 
its relationship to persecutors, voices, insight, and recovery. Data were gathered on 
92 patients with acute FEP on depression course, severity and experience of 
positive symptoms, insight and appraisals of illness using validated semi-structured 
interviews and questionnaires. Measures were repeated at 12 months. Malevolent 
voices, use of safety behaviours and subordination to persecutors were associated 
with depression and suicidal behaviour in acute FEP. Loss, Shame, low level 
continuing positive symptoms and longer duration of untreated psychosis were 
associated with post psychotic depression. Negative appraisals remained stable 
despite recovery in other symptom domains. Thus, depression and risk in early 
psychosis may be propagated by the personal significance and content of positive 
symptoms experienced. When in recovery, low level symptoms, longer period of 
illness and negative appraisals are significant factors.  
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1. Introduction  
 
Depression in psychosis has clearly been identified as a significant predictor of 
unmet need (Landolt et al., 2012), and is strongly associated with poor outcome and 
suicide(Challis et al., 2013; Upthegrove et al., 2010). Depression in the acute phase 
of schizophrenia often occurs at higher rates here than at other stages (Tapp et al., 
2001), yet the relationship between depression and acute psychotic symptoms is 
poorly understood (Cotton et al., 2012). Much of the current literature focuses on the 
post psychotic or chronic phase of illness (Buckley et al., 2009), often with little 
distinction between the two. We have previously shown that depression in the 
prodrome to first episode psychosis (FEP) will convey an increased risk of 
depression and suicidal behaviour at future points, however also that depression can 
break through at any time unheralded by previous depression (Upthegrove et al., 
2010). In post psychotic depression (PPD) few studies have focused on depression 
occurring after the first episode, however those that do show a higher rate of 
depression here than following relapse in established psychosis (Upthegrove, 2009; 
Upthegrove et al., 2010). Depression in schizophrenia and “non-affective psychosis” 
has been described as an intrinsic part of the syndrome itself, “revealed” as positive 
symptoms abate, or the result of anti-psychotic medication (Siris, 2004). Whether 
there is overlap between depression and features of negative symptoms, for 
example ahedonia and lack of volition, has been debated for some time with authors 
concluding that it is possible to identify depression within non-affective psychotic 
illness (Addington et al., 1992; Siris, 2004). Yet whether depression with and without 
psychosis is driven by the same process as is under-researched. We have yet to 
investigate the phenotype of depression in FEP in any real depth. A psychological 
model of post psychotic depression suggests a cognitive process of regained insight 
and appraisal of illness, and the impact of diagnosis as a label itself (Birchwood et 
al., 2005; Freeman and Garety, 2003). Recently increased interest has focused on 
the role of trauma for increasing the risk of affective instability and psychosis through 
enduring  biological impacts (Collip et al., 2013). Positive psychotic symptoms and 
illness appraisals can also provide fuel for this traumatic pathway, yet have not been 
studied in the acute phase, or to date in PPD following the first episode. The early 
years of psychosis remain high risk in terms of both suicidal behaviour and setting 
the trajectory for future functional outcome (Crumlish et al., 2009; Nordentoft et al., 
2002).  A fuller understanding of depression in FEP here has potential to translate in 
to more accurately targeted therapies and better outcomes for patients. This study 
aims to address this knowledge gap. Early psychosis, prior to longer term 
pharmacotherapy and during the first experience of acute psychotic symptoms, 
provides an ideal period to explore potential associations. We propose that 
psychological appraisals of positive symptoms and illness itself during this first 
experience will have maximum impact on the presence and persistence of 
depression.  
 
 
1.1 Aims and Hypotheses 
 
This study aims to provide an in-depth examination of depression in first episode 
psychosis, its relationship to other symptom dimensions and recovery in a phase 
specific manner. 
We hypothesise that in the acute phase of FEP threat from persecutors and voices, 
insight and negative illness appraisals will be associated with the presence of 
depression. In post psychotic depression following FEP, we hypothesise that greater 
insight and negative illness appraisals will continue to be related to the presence of 
depression. 
 
2. Methodology 
A cohort study using validated questionnaires and semi structured interviews was 
conducted. The study was set in the Birmingham Early Intervention Service (EIS), 
responsible for the assessment and treatment of all FEP presenting to Birmingham 
and Solihull Mental Health Foundation Trust (BSMHFT). The City of Birmingham, 
UK, has a population of 1.2M, and is a city of diverse socio-economic and ethnic 
communities. All patients meeting inclusion criteria were invited to participate at their 
first point of contact with the service. Research measures were completed by 
participants at home or inpatient unit with researchers (RU, KR, KB and RM) trained 
in the use of all measures to acceptable reliability.   
UK National Research Ethics Committee (NRES) approval was obtained for the 
study, reference number 0205437 
 
2.1 Inclusion and Exclusion Criteria 
 
Inclusion: 
 
• Age 16-35 years 
• Presenting in the acute phase of illness 
• Within 4 weeks of onset of treatment 
• First episode of psychosis: conforming to any ICD-10 category of psychotic 
illness (F20-29, F30.2, F31.2, F31.5 and F32.3(WHO, 1992). A broad diagnostic 
range was chosen in order to avoid premature exclusion of participants during a 
period of diagnostic uncertainty. 
 
      Exclusion: 
 
• Any previous treated episode of psychosis  
• Organic process as the primary diagnosis  
• Unable to communicate verbally in English 
 
 
2.2 Definitions 
 
Acute phase of FEP was defined as the onset of psychosis and before significant 
reduction in positive symptoms. Participants were grouped into those with and those 
without depression in the Acute as defined by a Calgary Depression Scale for 
Schizophrenia (CDSS) score of >7 (Addington et al., 1993).   
 
Post psychotic phase of illness was defined scoring on Positive and Negative 
Symptom Scale (PANSS) of less than 14 on positive scale total and less than 3 on 
any individual P1-7 item occurring following treatment as usual (with antipsychotic 
medication, case management and supportive therapy). Post Psychotic Depression 
(PPD) is defined as a depressive episode based on CDSS score of 7 or more at 
follow up. This is in keeping with ICD-10 definition of F20.4 post schizophrenia 
depression requires that positive symptoms “no longer dominate”(WHO, 1992) 
 
 
2.3 Research Measures 
 Baseline Measures; data collected at first presentation with FEP, therefore 
participants were in the acute phase of FEP, defined as the onset of psychosis and 
before significant reduction in positive symptoms: 
   2.31 Demographic details:  
Demographic data of age, gender, ethnicity, frequency and type of substance misuse 
were recorded.  
 
   2.32 Best-estimate lifetime diagnosis: 
Schedule for Clinical Assessment in Neuropsychiatry 2.1(SCAN)(WHO, 1999): This 
semi-structured interview, supplemented with informant responses and case note 
information, was used to assess lifetime diagnosis. Interviewers using the SCAN 
received formal training to acceptable reliability. SCAN diagnoses were generated 
using the CATEGO algorithms, with any discrepancy between clinical and computer 
generated diagnoses discussed by at least two researchers and a consensus 
reached. SCAN was also used to rate presence absence and date of any episodes 
of self harm. 
   
  2.33 Severity of current psychotic symptoms:  
Positive and Negative Symptom Scale (PANSS)(Kay et al., 1987):The current 
severity of psychotic symptoms, was captured using PANSS ratings, made on the 
basis of the standard semi-structured interview. 
   
  2.34 Duration of Untreated Psychosis (DUP):  
DUP was calculated using standardised and robust criteria as the interval between 
the onset of psychosis (the period when the patient experiences prominent psychotic 
symptoms as identified by the patient or by people observing the patient, equating to 
a score of 3 or more one any individual PANSS positive item score or 14 or more on 
the total positive scale) and the onset of criterion treatment (defined as antipsychotic 
medication for more than 14 days) following Larsen criteria (Larsen et al., 1996). 
  
 
  2.35 Depression Measures: 
a) Presence/absence of prodromal depression;  
The SCAN interview was used to determine the presence/absence of an episode of 
depression in the prodrome of first episode psychosis, with the prodromal period 
defined as the 6 month period before onset of psychotic symptoms. 
b) Presence/absence of acute depression  
Calgary Depression Scale for Schizophrenia(Addington et al., 1993); The CDSS is a 
structured interview which ensures separation from negative or extra pyramidal 
symptoms and is scored for the preceding 2 weeks. A score of 7 or more has 82% 
specificity and 85% sensitivity to predict a moderate or severe depressive episode 
(Addington D, 1996).  
 
   2.36 Insight and Illness Appraisals: 
a) Insight Scale (IS) (Birchwood et al., 1994); The self-report Insight Scale (IS) 
consists of 8 questions which measure the three standard dimensions of current 
insight; awareness of illness, awareness of symptoms and need for treatment. It has 
demonstrable validity and reliability. A total score is available for overall insight on a 
0-12 scale whereby 12 is full insight. Scores over 9 represent “good” insight. The IS 
compares favourably with other standard measures of insight used in psychosis 
research and has the benefit of being brief (Sanz et al., 1998). 
b) Personal Beliefs about Illness Questionnaire (PBIQ-R) (Birchwood et al., 
2000);The PBIQ-R is a self-report questionnaire grounded in social ranking theory, 
and was designed to evaluate how individuals appraise the personal threat of their 
illness. The PBIQ-R yields five subscales, assessing appraisals in terms of: ‘loss’, 
referring to the loss of social goals, roles and status; ‘entrapment’, evaluating the 
degree to which individuals feel unable to escape from their situation; ‘shame’, 
assessing the degree of shame experienced; ‘control’, referring to the degree to 
which individuals feel in control of their illness; and ‘group fit’, referring to the extent 
to which individuals feel that they no longer ‘fit in’ or are socially excluded because of 
their illness. 
c) Beliefs about Voices Questionnaire – Revised  (BAVQ-R)(Chadwick et al., 2000): 
The BAVQ-R is a validated self-report measure of patient’s beliefs and behaviour 
about auditory hallucinations. It assesses the perceived malevolence, benevolence 
and omnipotence of voices and patients’ resistance and engagement with their 
auditory hallucinations, and their emotional and behavioural reactions to them. The 
three sub-scales relate to: malevolence (six items: e.g. ‘My voice is punishing me for 
something I have done’ or “My voice is evil”); benevolence (six items: e.g. ‘My voice 
wants to protect me’ or “My voice is helping me to develop special powers and 
abilities”); omnipotence (six items e.g. “My voice is very powerful”) in addition to two 
sub scales reflecting an individuals’ reaction and behaviour in relation to their voice: 
resistance (7 items e.g. in relation to my voice I “tell it to leave me alone”) and 
engagement (8 items e.g. “I willingly do what my voice tells me to do”. All responses 
are rated on a 4-point scale: disagree (0); unsure (1); agree slightly (2); agree 
strongly (3). The measure thus assesses degree of endorsement of items. 
Individuals hearing more than one auditory hallucination complete the questionnaire 
for their ‘dominant voice’.   
d) Voice Power Differential Scale(Trower et al., 2004)  The perceived power of 
voices was rated using the Voice Power Differential Scale (VPD). This uses a 
differential scale linked to the concept of power and omnipotence.  The voice hearer 
is asked the question, “in relation to my voice I feel…..much more powerful than my 
voice “ to “we have the same power as each other” and “my voice is much more 
powerful than me”, giving a total power score. 
e) Details of Threat Questionnaire (DOT)(Freeman et al., 2001) The DOT is 
validated semi-structured interview that gains information as to the identity, type of 
threat and power of persecutors. Distress and ability to cope should the threat occur 
are self-rated on 0-10 linear scales and strength of belief on a self-report 0-100% 
scale 
f) Safety Behaviours Questionnaire (SBQ) (Freeman et al., 2001): The SBQ is a 
validated semi structured interview that rates seven specific types of safety 
behaviour; Avoidance, In-Situation safety behaviours, Escape, Compliance with 
persecutors demands, Help seeking, Aggressive acts and those carried out by the 
participant in the hope of reducing threat but judged by the interviewer to have no 
logical relation to the achievement of this aim (Delusional). For each positive 
response, frequency of engagement with safety behaviours is rated on a four-point 
scale. The SBQ has been shown to have good inter-related reliability and acceptable 
test-retest reliability (Freeman et al., 2007). 
 
 2.37 Follow Up Measures at 12 months: 
CDSS; IS; PANSS; PBIQ-R  
 
 
2.4 Statistical Analysis 
A database was created and data analysed using IBM® SPSS® Statistics Version 
19.  
Initial power calculations, based on one main outcome measure (PBIQ –R: 
Shame)(Iqbal et al., 2000) revealed that a sample size of 36 in each group of 
depressed and non-depressed participants would have 90% power to detect a 
medium effect size (defined 0.5 of a population standard deviation between the 
means respectively) on subscales of the PBIQ-R.  
 
Non-categorical data were tested for normal distribution using the Blom method of p-
p plots and parametric tests of significance were used to compare continuous 
measures between participants with and without depression in the acute and post 
psychotic phases. ANOVA was used as multiple hypothesis and interactions resulted 
in an increased chance of type 1 error, which is reduced in ANOVA compared to t-
tests (Rice, 1989). Where data were not normally distributed (DUP) non parametric 
tests were used. 
In order to determine the most significant predictors for the presence/absence of 
depression in the acute phase and presence/ absence of post psychotic depression, 
regression models were produced. The presence/ absence of depression in the 
prodrome, in addition to other significant variables from univarite analysis (as judged 
by significance <0.1) were entered in to a binary logistical regression analysis, after 
tests for mulitcolinearity. 
 
3. Results  
A total of 110 individuals met inclusion criteria. 16% (N=18) refused to participate, as 
they did not want to take part in any research, leaving 92 who entered the study. 
Those declining to participate did not significantly differ in age, gender or ethnic 
group from the participant group. The sample were 75% male, 35% White British had 
a mean PANSS positive score of 18.84 and with 70% meeting diagnostic criteria for 
schizophrenia. Full demographic and baseline clinical details of the study sample are 
given in table1. 
 
Full baseline data on voice appraisals (BAVQ-R scores) were available on 76% 
(N=70) participants: 19 (21%) reporting no auditory hallucinations and 3% (N=3) not 
completing the BAVQ-R. Full baseline data on persecutory beliefs (DOT and SBQ 
scores) were available on 82% (N=76) participants, with 17% (N=16) not reporting 
persecutors. All 92 participants completed the remaining baseline measures. All 
continuous variables demonstrated normal distribution, with the exception of DUP 
which had a right skewed distribution ranging from 0-644 days. 53% (N=49) reported 
thoughts of self-harm or suicide and 32% (N=30) reported acts of self-harm during 
the acute first episode. There was no relationship between reporting any depression 
in the acute phase and current substance misuse (Pearson x2 1.65 (d.f.1) p=0.15) 
 
89% participants completed 12 month follow up (N= 82). Full data were available for 
all participants completing follow up. Of those not completing follow up, 4 had 
disengaged from services and 6 declined to take part in follow up measures. This 
group did not differ in terms of age, gender or ethnicity from those participating in 
follow up. Baseline and clinical characteristics are reported in table1. 
 
 3.1 Rates of depression in the prodrome, acute psychotic phase and post psychotic 
phase:  
In the 6 months leading up to the first psychotic episode, 56% (N=51) participants 
experienced a clinically significant depressive episode (prodromal depression).  
In the acute phase of illness, 59% (N=54) presented with a moderate or severe 
depressive episode. Of all participants with depression in the acute phase of FEP, in 
37% (N=20) this occurred “de novo”, without prodromal depression, and in 63% 
(N=34) this was reported as continuous with prodromal depression.  
At follow up, 4 out of the 82 participants scored 14 or more on PANSS positive scale 
or greater than 3 on any individual P1-7 measure and were therefore continuing to 
experience significant positive psychotic symptoms, were not in a “post psychotic” 
phase, and thus were excluded from further analysis. Of the remaining 78, 37% 
(N=29) had a CDSS score of greater than 7. This defined the PPD group.   
22% (N=17) were depressed at each stage (prodromal, acute and PPD); 17% 
(N=14) were depressed in the prodrome and acute phases only; 20% (N=16) were 
not depressed in the prodrome, then were depressed in acute phase with or without 
PPD; 20% (N=16) were not depressed throughout. 5% (N=4) presented with PPD 
only. This pathway data has been previously reported in more detail (Upthegrove et 
al., 2010). 
 
When comparing depressed versus non depressed groups both at baseline and 
follow up, no significant differences were found in age, gender, or ethnicity. 
 
 3.2 Depression in the Acute Phase of FEP  
Participants in the depressed group did not have significantly higher scores on 
PANSS positive or negative rating scales.  
Voice hearers in the depressed group had higher BAVQ Malevolent and lower BAVQ 
Benevolence scores than voice hearers who did not have depression (F 
(1,68)=11.30  and F(1,68)=11.64 respectively, both p=0.001. In addition, depressed 
participants had significantly higher scores on BAVQ engagement F(1,68)=8.64, 
p=0.004).   
Participants reported a range of identities for persecutors, the most frequently cited 
being members of community (neighbours, friends, past acquaintances); 50%, and 
family members; 10%. Type of threat varied from direct physical threat (e.g. being 
killed, attacked or poisoned) to emotional threats (e.g. spreading rumours, controlling 
destiny, being cursed) with the most commonly cited as being imminently physically 
attacked at 47%. 
Depressed participants reported more powerful persecutors on the DOT measure (F 
(1,64)=4.34, p=0.04) and were more distressed by the threat from persecutors (F 
(1,65)=28.16, p=0.001) than those who were not depressed. In addition, they 
reported a higher strength of conviction (F(1,64)=4.51, p=0.03) and a diminished 
ability to cope with the current threat (F (1,65)=4.79, p=0.03). SBQ results revealed 
significantly more use of safety behaviours (total score) in the depressed group than 
the non-depressed group (F (1,72)= 9.56, p=0.003).See table 2, figure 1.  
The mean total IS score for the full sample was 9, indicating moderate insight across 
the sample. Total IS score did not differ between depressed and non-depressed 
participants; however, mean score on the key subscale, Awareness of Illness, was 
significantly higher in the depressed participants (F )1,90)= 4.64, p=0.03), see table 
2. 
Negative illness appraisals were greater in the depressed compared to non-
depressed participants. As measured by the PBIQ-R, depressed participants 
reported significantly higher appraisals on all measures: Loss (F (1,90)=23.19, 
p=0.001), Shame (F (1,90)= 10.22, p=0.002), Entrapment (F (1,90)= 26.62, 
p=0.001), Control (F (1,90)=21.88, p=0.001) and Group fit (F (1,90)= 20.35, 
p=0.001); see table 2, figure 1. 
 
The regression model contained 9 variables: prodromal depression, voice 
malevolence, benevolence (BAVQ-R), voice power (VPD), power of persecutors 
(DOT) and total safety behaviours (SBQ) together with loss, shame, entrapment 
(PIBQ-R). Due to multicolinearity with other significant variables, voice resistance 
(BAVQ-R), group fit and control (PBIQ-R) were not entered.  
The full model explaining depression in the acute phase of psychosis was significant, 
(X2 71.5, p<0.001 N78). The model as a whole explained between 54% (Cox and 
Snell R square) to 73% (Nagelkerke R square) of the variance of depression status, 
and correctly classified 85% of cases. 4 variables made a uniquely significant 
contribution to the model; depression in the prodrome (O.R. of 1.19), followed by 
Voice Malevolence (O.R. 1.36), Safety Behaviours (O.R. 1.11) and Entrapment (O.R. 
1.36). Other variables entered were not significant in the model. See table 4 for full 
details. 
 
3.3 Post Psychotic Depression: 
Participants with PPD had significantly longer DUP (p=0.02) and higher current 
PANSS positive score (F (1,79)= 3.9, p =0.04) than those who were not depressed. 
It should be noted that PANSS positive scores were those rating 1-3, ie at minimal 
levels, as participants scoring higher than 3 on any individual positive measure or 
over 14 on total positive score were excluded from the PPD group. Thus on-going 
but low level positive symptoms were higher in the PPD group. 
Participants with PPD did not have significantly higher scores on total insight 
however did score significantly higher on the “need for treatment” subscale (F 
(1,81)=4.33 p=0.04). Participants with PPD also scored significantly greater on 
PBIQ-R subscales of Control, Loss and Shame (F (1,81)= 8.54, F (1,75)= 9.78 and F 
(1,75)= 11.96 respectively, p < 0.05-0.005). See table 3. 
The regression model contained 8 variables: presence/absence of depression in the 
prodrome, presence/absence of depression in acute FEP, follow up PANSS positive 
score, DUP, Need for Treatment (I.S.), Loss, Shame and Control (PIBQ-R). The full 
model was significant, X2 32.53 , p<0.001 N82). The full model explained between 
34% (Cox and Snell R square) and 47% (Nagelkerke R square) of the variance of 
depression status, and correctly classified 62% of cases. 2 variables made a 
uniquely significant contribution to the model; DUP O.R. 1.1 and Loss O.R. 1.2. 
Other variables entered were not significant in the model. See table 4. 
 
 
 
 3.4 Stability of Negative Appraisals: 
Negative appraisals of illness; Loss, Shame, Entrapment, Control and Group Fit, 
were high at both baseline and endpoint, despite significant recovery over time on 
PANSS and depression measures. Entrapment showed a significant improvement; 
baseline (mean 14.64, sd 1.53) and endpoint (mean 12.90, sd 4.09) t (76)= 3.28, 
p=0.002.  
However there was no significant recovery in Loss; baseline mean 17.16 (sd 1.87) 
endpoint mean 16.67 (sd 5.43) t (76)= -1.5, p=0.15; Shame baseline mean 14.33, 
(sd 1.17) endpoint mean 13.83 (sd 4.23) t(76)= 0.35, p=0.7; Control baseline mean 
12.25 (sd 1.79) endpoint mean 11.22 (sd 4.13) t(76)= 1.68, p=0.09 or Group fit; 
baseline mean 11.53 (sd 0.92) endpoint mean 10.53, (sd 4.08) t(76)= 1.93, p=0.06. 
 
4. Discussion 
This study has shown that in acute first episode of psychosis, high rates of 
depression are present and associated with negative appraisals of illness in terms of 
relationship to voices, persecutors and the experience of psychosis itself. We also 
showed that those individuals who experienced post psychotic depression appraised 
their psychosis as more shaming, felt a greater sense of loss and less control, and 
also experienced on-going lower level positive symptoms and longer periods of 
untreated psychosis.  
This adds further evidence for the importance of the personal significance of 
psychotic symptoms previously shown in chronic samples and qualitative work 
(Birchwood et al., 2005; Sandhu et al., 2013), and the body of evidence surrounding 
awareness of insight and depression in established psychosis (López-Moríñigo et al., 
2012).  We have previously demonstrated the significance of depression in this acute 
phase, in terms of suicidality(Upthegrove et al., 2010), and the need thus for greater 
understanding of this symptom dimension. In this study we have been able to 
demonstrate that negative illness appraisals were a significant factor in the prediction 
of acute depression even after controlling for prodromal depression. Significant 
predictors in the logistic regression and relatively small odds ratios suggest a 
complex relationship and multiple smaller scale influences coming together to 
convey risk.   
 
Positive symptom severity and DUP were not predictive of depression in the acute 
phase, replicating other research (Schennach-Wolff et al., 2011).  We can interpret 
these findings to mean that there is no direct relationship between positive symptom 
severity, in terms of number or severity of symptoms, and depression. Rather, within 
a distinct depressive dimension in psychosis it is the personal significance of illness 
that is salient. We proposed that the personal threat from voices and persecutors, 
combined with the use of safety behaviours, would be predictive of depression, 
independent of severity of psychosis. This was upheld, with the experience of 
personal threat from voices and persecutors, and use of safety behaviours higher in 
the depressed compared with non-depressed groups. Findings presented in this 
study, in combination with other challenges to categorical classification (Craddock 
and Owen, 2010; Dutta et al., 2007; Fusar-Poli et al., 2013), highlight the importance 
and complexity of depression in psychosis. We have raised the possibility that in 
some patients depression is a reaction to the threat posed by perceived persecutors, 
demonstrating that voice malevolence, engagement in safety behaviours and 
entrapment were significantly associated in a model of depression in acute 
psychosis. Freeman and others (Freeman et al., 2001; Freeman et al., 2007) have 
also demonstrated the significance of safety behaviours in the development and 
maintenance of delusional belief and distress. This suggests the personal 
significance and reaction to perceived threat by voices and persecutors is overriding 
the severity of symptoms and is most significantly associated with depression.  
 
Models of the development of persecutory beliefs suggest a dynamic relationship 
between persecutor and subject, mediated by self-esteem; Udachina (Udachina et 
al., 2009) suggests that low levels of positive self-esteem have a direct association 
with experiential avoidance (intolerance of negative mental experiences) and the 
development of persecutory beliefs by preventing disconfirmatory evidence. An 
additional model is also possible; the personal appraisal of anomalous experiences 
drives on-going emotional dysfunction and through this further increases in positive 
symptoms. Thwarted escape, arrested flight and failure to exert or win control of 
symptoms through use of safety behaviours are key responses, drawing on innate 
dominant-subordinate relationship signals demonstrated in evolutionary models of 
depression (Gilbert et al., 2001). Learned helplessness, in response to unrelenting 
positive symptoms, also driving depression until treatment or “help” finally arrives.   
This is in keeping with recent advances in our understanding of anxiety and distress 
in psychosis whereby proneness to shame is driven by social anxiety disorder 
(Kesting and Lincoln, 2013; Rüsch et al., 2005). However, it is clear that while 
significant results were found in our study, odds ratios reported were only slightly 
over 1. Although this is statistically significant, it may indicate that it is the 
combination of multiple small effects that is ultimately responsible for depression. It 
is possible that other non-tested variables may influence depression at both stages. 
 
Insight overall was not linked to depression, however in the acute phase awareness 
of illness was significant, and in the post psychotic phase the need for treatment was 
greater in the depressed group. It is possible that participant numbers and power 
may be affecting the near significant results. However it is also possible that the 
process of recovery may be at play. Previous work demonstrated the significance of 
recovery style in psychosis. The internalization of medical models of illness, and 
need for treatment may be linked to a lowering of self-esteem and an assault on an 
internal locus of control in the face of on-going difficulties. (Drayton et al., 2011; 
Hastrup et al., 2013). An arrested “flight into health” with acceptance of the need for 
on-going medical care may convey a risk for PPD. 
DUP has been repeatedly shown to be a poor prognostic indicator in terms of 
symptom recovery and functional outcome (Marshall et al., 2005). The study results 
presented here indicate that DUP may also confer a risk for PPD. There was an 
association with PPD and on-going lower level positive symptoms. In univariate 
analysis, on-going low level positive symptoms were associated with depression. In 
the regression analysis, once previous depression is controlled for, DUP and Loss 
made a uniquely significant contribution to the model. We can interpret these 
findings to mean that whilst negative personal appraisals of psychosis, particularly 
loss, confer the most risk for PPD; on-going low level positive symptoms are also 
active and constitute an additional risk. In the overall picture of PPD, the sense is of 
a grinding down of hope for recovery, with a longer period of both untreated illness 
and persistent low level symptoms, in which future goals, forward plans and self-
esteem are allowed to whither. It also remains possible that PPD may overlap with 
the onset of negative symptoms, with a slower insidious onset and illness course 
more likely to include negative symptoms, rather than be understood as a purely 
independent symptomatic dimension in psychosis. Indeed studies investigating a 
dimensional approach to psychosis report multiple overlapping dimensions that 
include negative and affective clusters (Russo et al., 2014). 
Another novel finding presented here is that illness appraisals do not all “recover” in 
line with symptom resolution. Thus if one experiences the traumatic life event of FEP 
as a shameful event that alienates from a peer group, these appraisals are likely to 
continue. This knowledge may again go some way to answering the question 
regarding direction of causality when looking at results presented; whether it is the 
depression that is driving the negative appraisals or negative appraisal driving the 
depression. Negative appraisals remain high and relatively stable throughout, and 
could not therefore simply be an epiphenomenon of depression. There are two 
possible explanations for the failure of negative appraisals to reduce in line with 
symptom reduction: that these are long lasting and relatively enduring factors (trait); 
however it is also possible that they do change over time, but at a much slower rate 
and one not captured by the present study.  
 
4.1 Limitations  
This study has limitations that should be highlighted and result in caution in 
interpretation of findings. Participant numbers did not allow for subset analysis which 
would have revealed additional information, for example with depression arising “de 
novo” in each phase. It is also possible that participants experienced post psychotic 
depression not captured at 12 months (ie had recovered before measures were 
repeated). It is also possible that participants who declined to take part in the study 
had more severe symptoms, or more distress associated with these symptoms. Data 
on pharmacological therapy, including use of antidepressants in the follow up period 
was not recorded and could affect the prevalence of depression. More frequent 
follow up and repeated testing could potentially have increased numbers in the PPD 
group. Researchers administering semi-structured interviews were not blinded to 
baseline results and thus there is also a potential bias here. However, most key 
measures, including those on insight, appraisals and depression were self-report and 
this would minimise this potential effect. The inclusion of all FEP participants rather 
than only those with schizophrenia spectrum disorders could also be challenged. 
However, it is clear that diagnostic certainty is slim at this phase of illness. Results 
presented reflect the full FEP range and are thus generalizable to this group. We do 
report novel findings in an under researched area of FEP with significant clinical 
considerations and avenues for further research. 
 
 
4.2 Conclusion 
In bringing together the findings from this and previous work, an integrated model of 
depression in the course of first episode psychosis can be proposed. Initially, 
prodromal depression, a common occurrence, may be the result of shared 
environmental or genetic risk factors. Having experienced depression in the 
prodromal stage, an increased risk of further depression in the acute phase is 
propagated by appraisals of positive symptoms; malevolent content of voices, 
ineffective use of safety behaviours. Persecutors dominate, triggering innate 
dominant–subordinate relationship signals best understood from evolutionary 
psychology. Insight that is present is related to awareness of illness and 
accompanying feelings of shame and loss. 
 
Following recovery negative appraisals of the impact of illness with loss, shame and 
entrapment and are again associated with post psychotic depression. A long 
duration of untreated illness and persistent lower level positive symptoms add to 
these by way of reminders of past traumatic experiences and have a continued 
impact through perpetuation of feelings of loss and shame.  Loss, shame and 
entrapment remain enduring, state-like beliefs from their conception ready to re-
awaken depression at periods of future relapse or failed recovery.  
 
 It has been repeatedly demonstrated that the acute and early phases of psychosis 
contain a significant risk of suicide (Dutta et al., 2011; Polusny et al., 2011). 
Cognitive therapies are of therapeutic benefit (Peters et al., 2010; Turner et al., 
2014). Increased theoretical knowledge of the relationship between positive 
symptom dimensions and personal coping strategies can add to the effective 
development of such interventions and those aimed at reducing suicide risk. If 
negative appraisals remain stable, the implication is that they will not change without 
specific treatment. The post psychotic phase is often a period suggested for more 
intense psychological therapies, and the propensity to feel shamed by psychosis 
should be a key target for both therapy and service response models, delivered 
together with now routine interventions of psychoeducation and relapse prevention. 
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 Table 1 
Demographic and Baseline Clinical Details of Full Sample (n=92) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mean Age (years)            22.50 (s.d. 4.89) 
 
Gender 
 Male 75% (n=69)
 Female 25% (n=23) 
 
Ethnicity 
White British 35 % (n=31) 
Asian (all) 29% (n=28) 
Black- Caribbean 36% (n=33)
  
 
Substance Misuse 
 
None/ Infrequent use 
 
76% (n=68) 
Cannabis daily 23% (n=21) 
Other (Crack cocaine/ Heroin) 1% (n=3)
 
DUP (Days) 
 
         Mean: 207 (s.d.389)                                      Median: 59 
 
 
PANSS: Mean scores  
Positive  18.84  (s.d. 5.07) 
Negative  14.54   (s.d. 5.56) 
General 38.14 (s.d. 9.06)
 
 
SCAN Diagnosis 
ICD-10 
Schizophrenia 70% (n=65) 
Delusional Disorder 4.3% (n=4) 
Acute and Transient Psychotic
Disorder 
8.7 %(n=8) 
Other non-organic psychotic 
disorder 
3.3% (n=3)
Schizoaffective Disorder 2.2% (n=2)
Mania Severe with Psychotic
Symptoms 
 7.6% (n=7) 
Depressive Disorder Severe with
Psychotic symptoms 
 3.3% (n=3) 
Abbreviations 
 
PBIQ-R: Personal Beliefs about Illness Questionnaire 
DOT: Details of Threat 
SBQ: Safety Behaviours 
BAVQ: Beliefs about voices questionnaire 
VPD: Voice Power Differential 
DUP: Duration of Untreated Psychosis 
PANSS: Positive and Negative Symptoms Scale 
 
 
Table 2 
Comparison of Depressed / not Depressed in the Acute Phase of FEP  
 
 
                      Mean (s.d) 
 
ANOVA F (df) 
 
 
 
sig p= 
Depressed* 
n=54(59%) 
Not Depressed 
N=38(41%) 
  
 
PANSS Positive  17.9 20.4  4.48  0.06 
PANSS Negative  14.3 14.9 0.26  0.61 
Insight (IS) (n=92) Total Score 10.01 (4.30) 9.15 (3.97)  0.95 (1,90) 0.33 
Awareness of 
Symptoms 
2.68 (1.42) 2.87 (1.37) 0.12 (1,90) 0.72 
Awareness of Illness 3.87 (1.92) 3.59 (1.88) 4.64 (1,90) 0.03 
Need for Treatment 2.74(1.26) 2.43(1.43) 0.50 (1,90) 0.47 
Illness 
Appraisal(PBIQ-R) 
(n=92) 
Loss 18.96 (4.00) 14.95 (3.84) 23.19 (1,90) 0.001 
Shame 15.37 (2.83) 13.24 (3.56) 10.22  (1,90) 0.002 
Entrapment 16.00 (2.96) 12.71 (3.07) 26.62 (1,90) 0.001 
Group Fit 12.57 (2.45) 10.05 (2.88) 20.35 (1,90) 0.001 
Control 13.54 (3.13) 10.42 (3.15)  21.88 (1,90) 0.001 
Voices (BAVQ-R) 
(n=70**) 
Malevolence 9.08 (5.29) 5.17 (4.07) 11.30(1,68) 0.001 
Benevolence 3.89 (3.85) 7.40 (4.97) 11.64 (1,68) 0.001 
Omnipotence 8.30 (4.05) 6.93 (3.87) 2.02 (1,68) 0.16 
Resistance 14.53 (6.74) 10.87 (6.97) 4.89 (1,68) 0.03 
Engagement 8.33 (5.56) 4.83 (4.20)  8.64 (1,68) 0.004 
Voice Power 23.58 (5.18) 21.10 (6.00)  3.19(1,64) 0.07 
Persecutors 
(DOT and SBQ) 
 
(n=76**) 
Power  6.88 (2.45) 5.39 (3.29)  4.34 (1,64) 0.04 
Distress of belief  7.95 (1.97) 4.54 (3.97)  28.16 (1,65) 0.001 
Strength of belief  80.98 (23.21) 64.35 (39.55) 4.51 (1,64) 0.03 
Ability to Cope  4.10 (2.58) 5.70 (3.21) 4.79 (1,65) 0.03 
Use of Safety 
Behaviours  
21.73 (12.16) 11.77 (13.33) 9.56 (1,72) 0.003 
DUP (days)***   
Median 63 
 
Median 124 
  
S.E.126.04 
 
0.47 
 
              *Depressive episode as defined by ≥ CDSS 7 
              ** Please see text. N differs as not all participants with FEP reported voices and persecutors 
            *** Mann Whitney U 
 
 
 
 
 
 
 Table 3 
 Comparison of participants who did and did not have Post Psychotic depression 
 
 
Variable 
PPD* n=29 
(37%) 
(mean s.d) 
NO PPD  n=49 
(63%) 
(mean s.d) 
ANOVA 
  F* (df) 
 
    
 
sig p= 
 
 
PANSS POSITIVE 11.72 (3.34) 9.48(2.56) 3.9 (1,79) 0.05 
PANSS NEGATIVE 
 
12.13(5.11) 11.12(3.79) 1.0 (1,79) 0.27 
 
     
 
 
 
INSIGHT (IS) 
 
Total 11.00 (3.24) 9.36 (4.17) 3.4 (1,81) 0.07 
Awareness of Symptoms 3.16(1.09) 2.63(1.42) 3.11(1,81) 0.08 
Awareness of Illness 2.74(1.20) 2.44(1.39) 1.00(1,81) 0.32 
Need for Treatment 4.41 (1.41) 3.88(1.84) 4.33(1,81) 0.04 
ILLNESS 
APPRAISALS 
(PBIQ-R) 
n78  
 
Loss 18.07(3.94) 15.36(3.96) 9.78 (1,75) 0.005 
Shame 15.32(3.78) 12.97(3.67) 11.96 (1,75) 0.005 
Entrapment 13.42(3.67) 12.61(3.94) 2.6 (1,75) 0.15 
Control 12.49(4.09) 10.48(3.26) 6.64 (1,81) 0.04 
Group Fit 10.75(2.70) 10.36(4.09) 0.79 (1,75) 0.43 
 
DUP** 
  
Median:100 
 
Median 54 
  
S.E. 106.1 
 
0.02 
*Post Psychotic Depression= a depressive episode as defined by ≥ CDSS 7 at 12 months follow up, in absence of significant 
positive symptoms (see text). 
** Mann- Whitney U 
 
 
 
 
 
 
 
Table 4  
Logistical Regression Models 
 
 
 
Depression in Acute FEP  
 
Depressed N= 54 
Not Depressed N=38   
 
 
 
 B 
 
 
S.E. 
 
 
Wald  Sig O.R. 
 
95% C.I. for O.R. 
Prodromal Depression  1.61 0.76 4.35 0.03 1.19 1.13 1.90 
Voice Malevolence (BAVQ-R)  0.31 0.09 11.61 0.001 1.36 1.14 1.63 
Safety Behaviours (SBQ)  0.12 0.36 8,12 0.004 1.11 1.03 1.20 
Entrapment (PBIQ-R) 0.31 0.18 2.87 0.05 1.36 1.23 1.96 
 
Post Psychotic Depression 
 
Depressed N=29 
Not depressed N=49 
      
DUP  0.006 0.002 5.74 0.01 1.1 1.00 1.24 
Loss (PBIQ-R) 0.32 0.16 8.08 0.004 1.38 1.11 1.74 
 
 
 
 
 
Figure 1    
 
Appraisal of Psychosis in Acute First Episode 
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